Osteoporosis Trial, Recruiting (NCT07621679)

Osteoporosis Trial, Recruiting NCT07621679 Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre Condition: Osteoporosis

Printed from Voxsanity (voxsanity.com.au) — NCT07621679 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Osteoporosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 70 years of age or older, of any gender
People who are able to walk on their own, with or without a walking aid such as a cane or walker
People who have broken a bone after the age of 40, OR who have had two or more falls in the past 12 months, OR whose bone density scan result shows a T-score below -2.5, OR who are currently taking (or have recently paused) a Health Canada-approved medication for bone health — such as a bisphosphonate (taken by mouth or by infusion), denosumab, teriparatide, or romosozumab

Who may not be able to join:

People who have had a broken bone in the past 12 months
People who are unable to walk without supervision due to an active medical condition or a condition affecting memory or thinking
People who are not able to give their own informed consent to participate, or who are unable to communicate in English or French

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Suzanne Morin, MD, RI-MUHC

Phone: 514-934-1934

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07621679

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase: Not Applicable

Status: Recruiting

Condition: Osteoporosis

Trial contact: 514-934-1934

More information: https://clinicaltrials.gov/study/NCT07621679

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 70 years of age or older, of any gender
People who are able to walk on their own, with or without a walking aid such as a cane or walker
People who have broken a bone after the age of 40, OR who have had two or more falls in the past 12 months, OR whose bone density scan result shows a T-score below -2.5, OR who are currently taking (or have recently paused) a Health Canada-approved medication for bone health — such as a bisphosphonate (taken by mouth or by infusion), denosumab, teriparatide, or romosozumab

Who may not be able to join:

People who have had a broken bone in the past 12 months
People who are unable to walk without supervision due to an active medical condition or a condition affecting memory or thinking
People who are not able to give their own informed consent to participate, or who are unable to communicate in English or French

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Registry

ClinicalTrials.gov

Start date

7 May 2026

Est. completion

1 May 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Study recruitment rates (feasibility objective); Study retention rates (feasibility objective); Adherence to intervention (feasibility objective); Perceived acceptability and usability of the Heel2Toe sensor (feasibility objective)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov